Literature DB >> 29889280

Toxoplasma gondii: Biological Parameters of the Connection to Schizophrenia.

Jianchun Xiao1, Emese Prandovszky1, Geetha Kannan2, Mikhail V Pletnikov3, Faith Dickerson4, Emily G Severance1, Robert H Yolken1.   

Abstract

It is increasingly evident that the brain is not truly an immune privileged site and that cells of the central nervous system are sensitive to the inflammation generated when the brain is fighting off infection. Among the many microorganisms that have access to the brain, the apicomplexan protozoan Toxoplasma gondii has been one of the most studied. This parasite has been associated with many neuropsychiatric disorders including schizophrenia. This article provides a comprehensive review of the status of Toxoplasma research in schizophrenia. Areas of interest include (1) the limitations and improvements of immune-based assays to detect these infections in humans, (2) recent discoveries concerning the schizophrenia-Toxoplasma association, (3) findings of Toxoplasma neuropathology in animal models related to schizophrenia pathogenesis, (4) interactions of Toxoplasma with the host genome, (5) gastrointestinal effects of Toxoplasma infections, and (6) therapeutic intervention of Toxoplasma infections.

Entities:  

Mesh:

Year:  2018        PMID: 29889280      PMCID: PMC6101499          DOI: 10.1093/schbul/sby082

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  96 in total

1.  Toxoplasma gondii seropositivity and cognitive functions in school-aged children.

Authors:  A Mendy; E R Vieira; A N Albatineh; J Gasana
Journal:  Parasitology       Date:  2015-05-20       Impact factor: 3.234

2.  Relationship between Toxoplasma gondii infection and bipolar disorder in a French sample.

Authors:  Nora Hamdani; Claire Daban-Huard; Mohamed Lajnef; Jean-Romain Richard; Marine Delavest; Ophélia Godin; Emmanuel Le Guen; François-Eric Vederine; Jean-Pierre Lépine; Stéphane Jamain; Josselin Houenou; Philippe Le Corvoisier; Masayuki Aoki; Helene Moins-Teisserenc; Dominique Charron; Rajagopal Krishnamoorthy; Robert Yolken; Faith Dickerson; Ryad Tamouza; Marion Leboyer
Journal:  J Affect Disord       Date:  2012-12-27       Impact factor: 4.839

3.  Host Cell Preference of Toxoplasma gondii Cysts in Murine Brain: A Confocal Study.

Authors:  T C Melzer; H J Cranston; L M Weiss; S K Halonen
Journal:  J Neuroparasitology       Date:  2010

4.  HLA-DQA1/B1 alleles as putative susceptibility markers in congenital toxoplasmosis.

Authors:  Paulo Tadashi Shimokawa; Lília Spaleta Targa; Lidia Yamamoto; Jonatas Cristian Rodrigues; Kelly Aparecida Kanunfre; Thelma Suely Okay
Journal:  Virulence       Date:  2016-02-08       Impact factor: 5.882

5.  Differential effects of three canonical Toxoplasma strains on gene expression in human neuroepithelial cells.

Authors:  Jianchun Xiao; Lorraine Jones-Brando; C Conover Talbot; Robert H Yolken
Journal:  Infect Immun       Date:  2010-12-13       Impact factor: 3.441

6.  NURR1 mutations in cases of schizophrenia and manic-depressive disorder.

Authors:  S Buervenich; A Carmine; M Arvidsson; F Xiang; Z Zhang; O Sydow; E G Jönsson; G C Sedvall; S Leonard; R G Ross; R Freedman; K V Chowdari; V L Nimgaonkar; T Perlmann; M Anvret; L Olson
Journal:  Am J Med Genet       Date:  2000-12-04

7.  Reassessment of the role of aromatic amino acid hydroxylases and the effect of infection by Toxoplasma gondii on host dopamine.

Authors:  Zi T Wang; Steve Harmon; Karen L O'Malley; L David Sibley
Journal:  Infect Immun       Date:  2014-12-29       Impact factor: 3.441

Review 8.  Seasonality of births in schizophrenia and bipolar disorder: a review of the literature.

Authors:  E F Torrey; J Miller; R Rawlings; R H Yolken
Journal:  Schizophr Res       Date:  1997-11-07       Impact factor: 4.939

9.  Serological pattern consistent with infection with type I Toxoplasma gondii in mothers and risk of psychosis among adult offspring.

Authors:  Jianchun Xiao; Stephen L Buka; Tyrone D Cannon; Yasuhiro Suzuki; Raphael P Viscidi; E Fuller Torrey; Robert H Yolken
Journal:  Microbes Infect       Date:  2009-07-26       Impact factor: 2.700

10.  Chronic Toxoplasma infection modifies the structure and the risk of host behavior.

Authors:  Cristina Afonso; Vitor B Paixão; Rui M Costa
Journal:  PLoS One       Date:  2012-03-14       Impact factor: 3.240

View more
  22 in total

1.  Persistent Toxoplasma Infection of the Brain Induced Neurodegeneration Associated with Activation of Complement and Microglia.

Authors:  Ye Li; Emily G Severance; Raphael P Viscidi; Robert H Yolken; Jianchun Xiao
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

2.  Genotyping of Toxoplasma gondii Strains from Goats in Jahrom District, Southern Iran.

Authors:  Riam Sadooni; Hassan Rezanezhad; Kavos Solhjoo; Mohsen Kalantari; Behrad Pourmohammadi; Saiedeh Erfanian; Belal Armand; Masoud Esmi Jahromi
Journal:  Acta Parasitol       Date:  2021-10-28       Impact factor: 1.440

3.  Acute toxoplasmosis can increase serum dopamine level.

Authors:  Mostafa Omidian; Qasem Asgari; Mohammad Saleh Bahreini; Shokoufeh Moshki; Bahareh Sedaghat; Seyed Jafar Adnani Sadati
Journal:  J Parasit Dis       Date:  2021-09-14

4.  Toxoplasma gondii Seropositivity Interacts with Catechol-O-methyltransferase Val105/158Met Variation Increasing the Risk of Schizophrenia.

Authors:  Paula Rovira; Blanca Gutiérrez; Antonio Sorlózano-Puerto; José Gutiérrez-Fernández; Esther Molina; Margarita Rivera; Rafael Martínez-Leal; Inmaculada Ibanez-Casas; María Victoria Martín-Laguna; Araceli Rosa; Francisco Torres-González; Jorge A Cervilla
Journal:  Genes (Basel)       Date:  2022-06-18       Impact factor: 4.141

5.  Toxoplasma infection induces microglia-neuron contact and the loss of perisomatic inhibitory synapses.

Authors:  Gabriela L Carrillo; Valerie A Ballard; Taylor Glausen; Zack Boone; Joseph Teamer; Cyrus L Hinkson; Elizabeth A Wohlfert; Ira J Blader; Michael A Fox
Journal:  Glia       Date:  2020-03-11       Impact factor: 7.452

6.  Toxoplasma gondii Matrix Antigen 1 Is a Secreted Immunomodulatory Effector.

Authors:  Tadakimi Tomita; Debanjan Mukhopadhyay; Bing Han; Rama Yakubu; Vincent Tu; Joshua Mayoral; Tatsuki Sugi; Yanfen Ma; Jeroen P J Saeij; Louis M Weiss
Journal:  mBio       Date:  2021-05-18       Impact factor: 7.867

Review 7.  Impact of Plant-Based Foods and Nutraceuticals on Toxoplasma gondii Cysts: Nutritional Therapy as a Viable Approach for Managing Chronic Brain Toxoplasmosis.

Authors:  Sijie Tan; Wen Han Tong; Ajai Vyas
Journal:  Front Nutr       Date:  2022-02-25

Review 8.  Advances and Challenges in Understanding Cerebral Toxoplasmosis.

Authors:  Dirk Schlüter; Antonio Barragan
Journal:  Front Immunol       Date:  2019-02-14       Impact factor: 7.561

Review 9.  Oxidative Stress as a Possible Target in the Treatment of Toxoplasmosis: Perspectives and Ambiguities.

Authors:  Karolina Szewczyk-Golec; Marta Pawłowska; Roland Wesołowski; Marcin Wróblewski; Celestyna Mila-Kierzenkowska
Journal:  Int J Mol Sci       Date:  2021-05-27       Impact factor: 5.923

10.  Role of Toxoplasma gondii Chloroquine Resistance Transporter in Bradyzoite Viability and Digestive Vacuole Maintenance.

Authors:  Geetha Kannan; Manlio Di Cristina; Aric J Schultz; My-Hang Huynh; Fengrong Wang; Tracey L Schultz; Matteo Lunghi; Isabelle Coppens; Vern B Carruthers
Journal:  mBio       Date:  2019-08-06       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.